Physician

Mohammed A Khanzada, MD

According to 2025 Medicare claims, Mohammed Khanzada, MD (NPI: 1639143829) practices pain management in the Texarkana, TX-AR market, with the plurality of this provider's patient population coming from Bowie, TX. This provider's primary affiliated billing organization is PAIN TREATMENT CENTERS OF AMERICA, PLLC (NPI: 1841619731; TIN: 464786388) and primary practice location at 75503-1639.

Khanzada's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 438 traditional Medicare patients, billed 11,828 HCPCS/CPT codes, and received $670,676 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 10,073 prescription claims across 1,153 beneficiaries totaling $268,255 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). DME data shows 18 claims. Open Payments data shows 2 records totaling $50. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $56,776 to $670,676. Similarly, Part D prescription costs have moved sharply higher in recent years, from $75,376 to $268,255. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$335K$671K2015 Medicare payment: $56,776 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $48,193 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $36,595 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $44,622 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $45,375 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $372,326 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $434,620 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $565,488 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $632,356 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $670,676 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015240466$56,776
2016216396$48,193
2017227346$36,595
2018352446$44,622
2019369445$45,375
20203776,839$372,326
20213945,044$434,620
20224565,773$565,488
20234356,937$632,356
202443811,828$670,676

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$134K$268K2020 Drug cost: $75,376 (USD; Tot_Drug_Cst)2021 Drug cost: $109,352 (USD; Tot_Drug_Cst)2022 Drug cost: $154,759 (USD; Tot_Drug_Cst)2023 Drug cost: $256,177 (USD; Tot_Drug_Cst)2024 Drug cost: $268,255 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20204362,751$75,376
20216383,718$109,352
20228965,692$154,759
20231,0439,131$256,177
20241,15310,073$268,255

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$7.0K$14K2024 Medicare payment: $13,964 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20241818$13,964

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0482Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms3901,410$190
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3871,375$76
80307Testing for presence of drug, by chemistry analyzers4001,707$60
83735Magnesium level325454$6
84100Phosphate level325456$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen7,277212,263$203,843
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen70220,443$21,704
Acetaminophen-CodeineAcetaminophen With Codeine2556,886$4,972
BuprenorphineBuprenorphine14392$4,420
Morphine Sulfate ErMorphine Sulfate1093,133$4,347

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L0650Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelfN1818$13,964

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$50Nevro Corp.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mohammed A. Khanzada, MD?

Tedicare shows public-source Medicare data for Mohammed A. Khanzada, MD (NPI 1639143829), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammed A. Khanzada, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohammed A. Khanzada, MD?

Mohammed A. Khanzada, MD is linked to PAIN TREATMENT CENTERS OF AMERICA, PLLC (billing NPI 1841619731) in the available physician profile data.

Does Mohammed A. Khanzada, MD have Open Payments data?

Mohammed A. Khanzada, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.